Recalls from The Harvard Drug Group LLC

• Major Methylergonovine Maleate Tablets (opens in a new tab)
  Moderate risk, FDA, Jun 22, 2026, Wrong drug strength
• Major Pharmaceuticals Omega-3-Acid Ethyl Esters Capsules (opens in a new tab)
  Moderate risk, FDA, Apr 17, 2026, Quality testing problem
• Major Pharmaceuticals Memantine Hydrochloride Extended-Release Capsules (opens in a new tab)
  Moderate risk, FDA, Apr 10, 2026, Drug dissolving problem
• Major Pharmaceuticals Midodrine Hydrochloride Tablets (opens in a new tab)
  Moderate risk, FDA, Mar 3, 2026, Packaging defect

Data: Recall Canary (opens in a new tab)